Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENKLA-M : Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia

NCT07249476 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT07249476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07249476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENKLA-M : Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
June 1, 2030
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukaemia (acute lymphoblastic), leukaemia (acute myeloid), myelodysplastic syndrome